Long-lasting immunity is key to the success of cancer vaccines. CVI’s Dr. John Liao and Dr. Nora Disis discuss factors that may help predict which patients will develop long-term immunity after vaccination. Read more here: www.uwcvi.org/post/what-ma... #CancerResearch

A new clinical trial reveals that CVI’s WOKVAC cancer vaccine was safe and generated the desired immune response against non-metastatic breast cancer. Read more: www.uwcvi.org/post/wokvac-... #ClinicalTrial #CancerVaccine #CancerResearch

Congresswoman Pramila Jayapal visited the CVI to learn how cancer vaccines could transform treatment, prevent recurrence, and one day stop cancer before it starts. Sustained investment in research is key to making this future possible. Read more here: www.uwcvi.org/post/inside-... #CancerResearch

Dr. Nora Disis, CVI Director, joined the Presidential Select Symposium at the 2026 AACR meeting. From immune-training vaccines to approaches targeting DCIS and obesity-related risk, she shared how CVI is advancing prevention. Read here: www.uwcvi.org/post/dr-nora... #CancerResearch #CancerVaccines

Dr. Kiran Dhillon, CVI Executive Director, joined global leaders at XPRIZE Global Visioneering, tackling humanity’s biggest challenges. She presented a bold prize concept that aligns with the CVI mission: vaccines that prevent and treat cancer. Read more: www.uwcvi.org/post/cvi-lea...

The Lancet Oncology’s article features a $200 million initiative to fund cancer vaccine clinical trials. Dr. Disis, Director of the CVI, called this initiative a promising start. Read more here: www.uwcvi.org/post/a-new-i... #CancerVaccine

Years of dedication and research have brought COLOVAC from concept to reality, making colon cancer prevention more than just a vision. Learn more and donate here to support our work: uwcvi.org/donate-now #CancerVaccine #ColonCancer #EnoughCRC

Dr. Nora Disis, CVI Director, Editor-in-Chief of JAMA Oncology, and Deputy Editor of JAMA, joined Healthcare Unfiltered with Dr. Chadi Nabhan to discuss peer review, impact factors, and how medical evidence is evaluated before publication. Learn more here: www.uwcvi.org/post/team-sc... #Podcast

COLOVAC can help people with high genetic risk, such as FAP, precancerous polyps, or those who have been treated to remission after a colon cancer diagnosis. We anticipate a Phase I clinical trial for COLOVAC to begin within 3 years. Prevention is within reach. #CancerVaccine

Dr. Nora Disis, CVI Director, was featured on KING 5 News to talk about our colon cancer vaccine progress. Read more details: www.uwcvi.org/post/king-5-... Dr. Disis PC: Lisa Stromme Warren #CancerVaccine @uwmnewsroom.bsky.social @uwmedicine.bsky.social @king5news.com.web.brid.gy @nbcnews.com

Dr. Nora Disis and Dr. Kiran Dhillon of the UW Cancer Vaccine Institute have been invited to the 2026 XPRIZE Global Visioneering Brain Trust (Health). They will help shape bold solutions to accelerate innovation and advance transformative cancer prevention and treatment. #UWCVI #XPRIZE

COLOVAC reduced the number of intestinal and colon polyps in mouse models of colon cancer, promising results in its ability to intercept colon cancer. We are one step closer to a human clinical trial. Read more about COLOVAC here: www.uwcvi.org/post/colon-c... #COLOVAC #UWCVI #CancerVaccine

CVI’s Dr. Natasha (Tasha) Hunter has been named the 2026 Athena Endowed Award recipient for Excellence in Breast Cancer Research. The award honors an early career researcher whose recent work advances breast cancer prevention, detection, diagnosis, or treatment. #WomenInStem PC: Fred Hutch

COLOVAC is designed to target specific proteins that appear at abnormally high levels in precancerous polyps and colorectal tumors. We hope to stop cancer at its earliest stages, long before it becomes life-threatening. #CancerPrevention #COLOVAC

Dr. Kiran Dhillon (CVI Executive Director) co-authored a Viewpoint with Dr. Lennard Lee (University of Oxford) in JAMA Oncology, calling for a renewed commitment to cancer vaccines. We are proud to be at the forefront of the fight against cancer. Read more here: www.uwcvi.org/post/dr-kira...

Imagine a vaccine that teaches the immune system to detect and eliminate the earliest signs of colon cancer. That’s COLOVAC, our colon cancer vaccine in development. It’s changing how we think about cancer prevention. Follow us to learn more. #CancerVaccine #EnoughCRC

Some inherited genetic mutations dramatically increase the likelihood of developing colon cancer, and at younger ages. The CVI is working toward a future where risk doesn’t have to become reality, by advancing vaccines that intercept cancer before it starts. #CancerPrevention #UWCVI

March is Colorectal Cancer Awareness Month. Colorectal cancer is on the rise, and it’s affecting younger adults more than ever before Intercepting cancer early saves lives. Let’s talk about prevention, screening, and care. #ColorectalCancerAwareness #CancerPrevention #EnoughCRC #UWCVI

A recent study showed that our HER2 ICD DNA vaccine, which tells a patient’s cells to create HER2 fragments instead of introducing protein fragments (peptides), demonstrated stronger and more comprehensive immune activation. Read more: www.uwcvi.org/post/dna-bas...

A new clinical trial reveals that CVI’s WOKVAC, a HER2-targeted cancer vaccine, may reduce breast cancer recurrence and doubled HER2-specific immune responses. Read more here: www.uwcvi.org/post/cvi-s-w... #CancerResearch #ClinicalTrial

The Cancer Vaccine Institute is proud to share a year-in-review that highlights the research, achievements, and progress made in 2025. Read our newsletter here: mailchi.mp/f1e9b3bb9637... #CancerResearch #CancerVaccines

New research from the UW Cancer Vaccine Institute reveals a surprising link between the gut microbiome and breast cancer and how a precision probiotic could help boost immune response. Read more here: www.uwcvi.org/post/gut-bac... #CancerResearch #ClinicalTrials #BreastCancer

In a retrospective study, we found patients with HER2+ breast cancer had up to a 57% reduction in brain mets (vs. historical controls) when given a HER2-targeted cancer vaccine. Our next steps are a Phase II clinical trial. Read more: www.uwcvi.org/post/her2-di... #CancerResearch

Special thanks to In Concert for Cancer for spreading their love for music and passion for ending cancer with the community! Michele Abrams and Jeff Christensen presented a $75,000 check to the CVI earlier this week. #InConcertforCancer #CancerVaccineInstitute #UWMed

Dr. Nora Disis joined ACSCAN's flagship WA Research & Policy Breakfast, along with by Dr. Nancy Davidson @fredhutch.org to explore evidence-based strategies for reducing the cancer burden + ensuring equitable access to care. Blog: www.uwcvi.org/post/dr-nora...

The Cancer Vaccine Institute team has arrived in San Antonio for @sabcs.bsky.social and we'd love to connect to share more about our work! Reach out to Executive Director Dr. Kiran Dhillon at [email protected] to connect in San Antonio this week! #SABCS

Dr. Disis was honored at Huskies for a Cure, sharing CVI’s mission community and @uwmedicine.bsky.social @uwnews.uw.edu leaders. Our team cheered as the Huskies took the field — an evening of energy, pride, and purpose! 💜🐾#HuskiesForACure www.uwcvi.org/post/huskies...

Last month, we shared real progress-1 vaccine in Phase II, 2 more in the pipeline-and honored the voices that make this work matter. Grateful to Katerie Schei, Joe White & Betty Merken, and to every thriver who filled the room with hope Read more: www.uwcvi.org/post/changin...

Welcome Dr. Natasha Hunter, MD, as CVI’s new Director of Clinical Trials! 👏 She’s leading phase II trials of our cancer vaccines + advancing translational science to improve patient outcomes. More here: www.uwcvi.org/post/welcomi... #CancerVaccines #ClinicalTrials #CancerResearch

💗 Huge thanks to the @kunifoundation.bsky.social for their leadership, vision, and commitment to transforming cancer care. Their support powers our research at the Cancer Vaccine Institute and lifts up scientists across the Pacific Northwest. Together, we’re advancing science and delivering hope.

This #BreastCancerAwarenessMonth, we honor Pacific Northwest researchers driving innovation in cancer care and early detection. Read our latest blog post ⬇️ #PNWCancerResearch #Cancer #CancerInnovation #SupportScience #EarlyDetection #CancerResearch #Community #Philanthropy

Big news! 🎉 Dr. Nora Disis has been named a 2025 Champion of SITC by @sitcancer for her leadership in cancer immunotherapy. Honored. Inspired. Grateful. 🏆 Learn more: www.uwcvi.org/post/celebra... #SITC2025 #CancerResearch #Immunotherapy #WomenInScience

October is Breast Cancer Awareness Month, and we're thrilled to welcome back the Safeway Check-Stand Campaign! Our sincere thanks to Safeway and their shoppers for supporting innovation in cancer prevention and treatment. #CVI #BreastCancerAwareness

Dr. Nora Disis had the honor of speaking on stage at the 14th Annual Benefit Show hosted by In Concert for Cancer, an unforgettable evening filled with powerful performances and heartfelt stories. Thank you to everyone who came together to support our work. #CancerVaccines #CVI

After 20 years of relentless research, ovarian cancer vaccines are within reach. But with federal funding in decline, we need your help to keep momentum alive. Let’s make ovarian cancer history—together. 💙 Support the work: www.uwcvi.org/donate-now #OvarianCancer #CancerVaccines #ResearchMatters

Advocates like Katerie Laughlin Schei make our work possible. With federal funding at risk, philanthropic support is vital to keep cancer vaccine research moving forward. Help us reach the patients who need it most. 💙 Donate today: www.uwcvi.org/donate-now #OvarianCancer #CancerResearch

18 years after a stage IV diagnosis, Jamie’s still here—and advocating for others. Her story fuels our push for faster breakthroughs in ovarian cancer. Learn how vaccines are changing the future at CVI: uwcvi.org/post/bold-progress-to-end-ovarian-cancer-how-vaccines-are-changing-the-future

🧬 Ovarian cancer is one of the deadliest gynecologic cancers—but breakthroughs are finally within reach. At the UW CVI, 4 promising vaccines are advancing toward a future of prevention & lasting treatment. Hope is no longer hypothetical. It’s happening. tinyurl.com/42xa6ya4

🩵 September is #OvarianCancer Awareness Month. One of the deadliest gynecologic cancers saw its federal research funding slashed from $45M to $15M. Cancer vaccine breakthroughs are near—but progress may stall. 📢 RT to amplify. #OvarianCancer

At the CVI, Adam Prince works with over 30,000 frozen blood samples, some dating to the 1980s. Stored in liquid nitrogen, this living archive reveals how the immune system responds to our cancer vaccines, even decades later. Meet Adam #OnTheCancerResearchFrontier: www.uwcvi.org/post/on-the-...

Thank you, Valley Girls & Guys, for your $500,000 pledge to CVI. “Our mission at Valley Girls & Guys! is to harness the power of community to support cancer patients and their families, and CVI’s commitment to a future without cancer aligns perfectly with our values,” said Founder Tina McDonough.

🎧🧬🎙️ Listen to Dr. Mary (Nora) Disis from @uwcvi.bsky.social where she discusses groundbreaking research on cancer prevention through vaccines & more. Many thanks to Dr. Disis & the UW CVI team for your visionary work! #CancerResearch #SupportScience #CancerPrevention #WomenInScience #Philanthropy

“Every cancer patient has an immune response against their cancer. The problem is the immune responses aren’t the type of immune responses you need to kill your cancer.” That’s where cancer vaccines come in, explains CVI's Dr. Nora Disis with @outperformcancer.bsky.social: youtu.be/XmgmiLYATGQ?...

Brava, Dr. Nora Disis! CVI's Director was named a Woman of Excellence, Brava! honoree by the Women’s University Club of Seattle. She shared in her remarks the “Four F’s” — Fortitude, Focus, Fearlessness, and Fun — that contributed to her finding meaning in science: www.uwcvi.org/post/dr-nora...

We're honored that CVI's @kirandhillon.bsky.social took the stage amongst innovators to address the critical gaps in women’s health at the #PowerOfX Summit. Alongside Kristen Dahlgren (Cancer Vaccine Coalition), she spoke about the future of breast cancer treatment with lifesaving #cancervaccines.

CVI Director Dr. Nora Disis was awarded a $300,000 grant from the Rivkin Center for Ovarian Cancer Research and Andy Hill Cancer Research Endowment (CARE) Fund to advance the development of a vaccine designed to prevent ovarian cancer’s metastatic spread. #OvarianCancer #CancerVaccines

As we close the chapter on 2024, the Cancer Vaccine Institute is proud to share a year-in-review that underscores a journey of progress and promise. Take a look at our latest newsletter: mailchi.mp/d12d4249ea98...

Our very own Dr. Nora Disis was the inaugural Wayne Kuni Award for Cancer Innovation by the Kuni Foundation. In honor of its founder, Wayne Kuni, the $1 million award recognizes transformative, disruptive contributions to the field of cancer research. Read more: www.uwcvi.org/post/dr-nora...

Thank you In Concert For Cancer for your gift to CVI. “Supporting the lifesaving work of Dr. Nora Disis and her team is a true honor, and this gift marks a deeply personal milestone in my commitment to making a meaningful impact in the fight against cancer,” said Michele Abrams, Founder.

It's been a thrilling week @uwcvi.bsky.social with Founder and Director, Dr. Nora Disis, receiving the Wayne Kuni Award for Cancer Innovation ($1M unrestricted funds) from @kunifoundation.bsky.social & the Lifetime Achievement Award in Healthcare Leadership from the Puget Sound Business Journal! 🙏